NXPH4 and thymoma: The study highlighted a higher expression of NXPH4 in almost all cancers except Kidney renal papillary cell carcinoma (KIRP), Acute Myeloid Leukemia (LAML), Skin Cutaneous Melanoma (SKCM), Thyroid carcinoma (THCA), and thymoma (THYM) (Figure 1A).